6-32396360-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001304561.2(BTNL2):āc.757C>Gā(p.Gln253Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000238 in 1,612,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001304561.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000155 AC: 38AN: 244606Hom.: 0 AF XY: 0.000120 AC XY: 16AN XY: 133454
GnomAD4 exome AF: 0.000240 AC: 351AN: 1460388Hom.: 0 Cov.: 33 AF XY: 0.000226 AC XY: 164AN XY: 726444
GnomAD4 genome AF: 0.000217 AC: 33AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.757C>G (p.Q253E) alteration is located in exon 5 (coding exon 5) of the BTNL2 gene. This alteration results from a C to G substitution at nucleotide position 757, causing the glutamine (Q) at amino acid position 253 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at